36081818|t|Cognitive changes mediated by adenosine receptor blockade in a resveratrol-treated atherosclerosis-prone lupus mouse model.
36081818|a|Background and aim: Resveratrol is a bioactive molecule used in dietary supplements and herbal medicines and consumed worldwide. Prior work showed that resveratrol's anti-atherogenic properties are mediated in part through the adenosine A2A receptor. The present study explores the potential contribution of adenosine A2A receptor activation to neuroprotective action of resveratrol on cognitive deficits in a model of atherosclerosis-prone systemic lupus erythematosus. Experimental procedure: Using behavioral analysis (open field, static rod, novel object recognition) and QRT-PCR, this study measured working memory, anxiety, motor coordination, and expression of mRNA in the brain. Results and conclusion: Data indicate that resveratrol increases working memory, on average but not statistically, and shows a trend towards improved motor coordination (p = 0.07) in atherosclerosis-prone lupus mice. Additionally, resveratrol tends to increase mRNA levels of SIRT1, decrease vascular endothelial growth factor and CX3CL1 mRNA in the hippocampus. Istradefylline, an adenosine A2A receptor antagonist, antagonizes the effects of resveratrol on working memory (p = 0.04) and the expression of SIRT1 (p = 0.03), vascular endothelial growth factor (p = 0.04), and CX3CL1 (p = 0.03) in the hippocampus.This study demonstrates that resveratrol could potentially be a therapeutic candidate in the modulation of cognitive dysfunction in neuropsychiatric lupus, especially motor incoordination. Further human studies, as well as optimization of resveratrol administration, could confirm whether resveratrol may be an additional resource available to reduce the burden of cognitive impairment associated with lupus. Additionally, further studies need to address the role of A2A blockade in cognitive function among the autoimmune population. Section: 3. Dietary therapy/nutrients supplements. Taxonomy classification by EVISE: autoimmunity, inflammation, neurology.
36081818	63	74	resveratrol	Chemical	MESH:D000077185
36081818	83	98	atherosclerosis	Disease	MESH:D050197
36081818	105	110	lupus	Disease	MESH:D008180
36081818	111	116	mouse	Species	10090
36081818	144	155	Resveratrol	Chemical	MESH:D000077185
36081818	276	287	resveratrol	Chemical	MESH:D000077185
36081818	295	306	atherogenic	Disease	MESH:D050197
36081818	364	373	 receptor	Gene	11540
36081818	361	364	A2A	DNAMutation	tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0;OriginalGene:93759;CorrespondingGene:23411;CorrespondingSpecies:10090
36081818	445	454	 receptor	Gene	11540
36081818	442	445	A2A	DNAMutation	tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0;OriginalGene:93759;CorrespondingGene:23411;CorrespondingSpecies:10090
36081818	495	506	resveratrol	Chemical	MESH:D000077185
36081818	510	528	cognitive deficits	Disease	MESH:D003072
36081818	543	558	atherosclerosis	Disease	MESH:D050197
36081818	565	593	systemic lupus erythematosus	Disease	MESH:D008180
36081818	745	752	anxiety	Disease	MESH:D001007
36081818	854	865	resveratrol	Chemical	MESH:D000077185
36081818	994	1009	atherosclerosis	Disease	MESH:D050197
36081818	1016	1021	lupus	Disease	MESH:D008180
36081818	1022	1026	mice	Species	10090
36081818	1042	1053	resveratrol	Chemical	MESH:D000077185
36081818	1087	1092	SIRT1	Gene	93759
36081818	1142	1148	CX3CL1	Gene	20312
36081818	1174	1188	Istradefylline	Chemical	MESH:C111599
36081818	1206	1215	 receptor	Gene	11540
36081818	1203	1206	A2A	DNAMutation	tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0;OriginalGene:93759;CorrespondingGene:23411;CorrespondingSpecies:10090
36081818	1255	1266	resveratrol	Chemical	MESH:D000077185
36081818	1318	1323	SIRT1	Gene	93759
36081818	1387	1393	CX3CL1	Gene	20312
36081818	1453	1464	resveratrol	Chemical	MESH:D000077185
36081818	1531	1552	cognitive dysfunction	Disease	MESH:D003072
36081818	1556	1578	neuropsychiatric lupus	Disease	MESH:D020945
36081818	1591	1611	motor incoordination	Disease	MESH:D002524
36081818	1621	1626	human	Species	9606
36081818	1663	1674	resveratrol	Chemical	MESH:D000077185
36081818	1713	1724	resveratrol	Chemical	MESH:D000077185
36081818	1789	1809	cognitive impairment	Disease	MESH:D003072
36081818	1826	1831	lupus	Disease	MESH:D008180
36081818	1891	1894	A2A	DNAMutation	tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0;OriginalGene:93759;CorrespondingGene:23411;CorrespondingSpecies:10090
36081818	2044	2056	autoimmunity	Disease	MESH:D001327
36081818	2058	2070	inflammation	Disease	MESH:D007249
36081818	Positive_Correlation	MESH:D000077185	93759
36081818	Association	MESH:D000077185	HGVS:c.2A>A;CorrespondingGene:23411
36081818	Negative_Correlation	MESH:C111599	HGVS:c.2A>A;CorrespondingGene:23411
36081818	Association	MESH:D000077185	MESH:D002524
36081818	Negative_Correlation	MESH:C111599	11540
36081818	Association	HGVS:c.2A>A;CorrespondingGene:23411	MESH:D003072
36081818	Association	MESH:D003072	11540
36081818	Negative_Correlation	MESH:D000077185	20312
36081818	Negative_Correlation	MESH:C111599	93759
36081818	Association	MESH:D000077185	MESH:D020945
36081818	Negative_Correlation	MESH:D000077185	MESH:D008180
36081818	Negative_Correlation	MESH:D000077185	MESH:D050197
36081818	Negative_Correlation	MESH:D000077185	MESH:D003072
36081818	Negative_Correlation	MESH:C111599	20312
36081818	Association	MESH:D000077185	11540
36081818	Negative_Correlation	MESH:C111599	MESH:D000077185
36081818	Association	MESH:D003072	23411

